MedPath
TGA Approval

TUZUCIP trastuzumab 150 mg powder for injection vial (368990)

368990

TUZUCIP trastuzumab 150 mg powder for injection vial

Cipla Australia Pty Ltd

July 18, 2022

Medicine

Medicine

Active

Registered

Active Ingredients

Trastuzumab

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.